Potency of HAART affects viral replication and the efficacy of HIV-1 therapy and can be assessed by HIV-1 DNA levels in PBMC
Lisa M. Frenkel1,2*, Yang Wang3, Gerald H. Learn3,
Ann J. Melvin1,
Giovanina M. Ellis1, Jennifer L. McKernan1, Shannon M. De Vange1,
Kathleen M. Mohan1, Sarah Holte4, Gail L. Sylva1, Wilscott E. Naugler1^,
Madhumita Mahalanabis1#,
Ingrid A. Beck1, Paul A. Lewis5, Laura M. Heath3,
Nicole H. Tobin1, Diane Pawluk1, James I. Mullins2,3,6.
Departments of 1Pediatrics, 2Laboratory Medicine, 3Microbiology,
4Biostatistics, and 6Medicine, University of Washington School of Medicine,
Seattle, WA 98195 and
5Oregon Health Sciences University, Portland, Oregon
Current affiliations: ^Oregon Health Sciences University, Portland, Oregon and
#Department of Microbiology, University of Washington School of Medicine, Seattle, WA
Journal of Virology 2003. 77(10):5721-5730
Abstract
Abstract from PubMed Medline
This article is available as HTML
and a PDF
file from Journal of Virology. To view these you
will need a subscription account with Journal of
Virology and, for the PDF file, a program such as Adobe
Acrobat Reader.
Additional material from this study is available.
*Please address comments or questions concerning this
study to:
Lisa M. Frenkel, M.D.
4800 Sand Point Way, NE; CH-32
University of Washington School of Medicine
Seattle, WA 98102
Tel. 206-528-5140
Fax. 206-527-3890
email: lfrenkel@u.washington.edu
Back
to Mullins Lab Home Page
|
